PAR 2.13% 23.0¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Update and Appendix 4C - quarterly, page-29

  1. 4,271 Posts.
    lightbulb Created with Sketch. 6766
    Huts7, I actually envisage a day when we have a really awesome Big Pharma Partner...we both work together on Massive Global roll out...hitting even more than 22 countries in the first year (Is Mozz on drugs? Well Humira did it, look em' up)...we surpass massive sales targets...jumping year on year...but you know what...we have a very large R & D Team...whole departments...and they work on the next upcoming indications...doing the pre clinical work...setting up info for FDA...beginning prep work for Phase 1 and 2's...multiple indications in parallel, yeah I'm talking multi layering future type revenue.

    Its for these days we must have some exposure as well, still left. We are early and informed. Think of all the investors and people to come in and are still yet to even hear about us, what we are capable of and finally take a punt and join us.



    Completely my thoughts


    Last edited by Mozzarc: 28/07/22
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.0¢
Change
-0.005(2.13%)
Mkt cap ! $80.45M
Open High Low Value Volume
24.0¢ 25.5¢ 23.0¢ $169.7K 718.4K

Buyers (Bids)

No. Vol. Price($)
8 152403 22.5¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 9990 1
View Market Depth
Last trade - 16.10pm 12/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.